Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
La formación de médicos especialistas dermatólogos con un alto grado de competencia y eficiencia a nivel internacional, con bases científicas, asistenciales, de investigación, éticas y humanísticas apropiadas para brindar una atención de excelencia, asegurando el desarrollo profesional y liderazgo en la comunidad donde labore y que contribuya a mejorar su nivel de salud. Así como contribuir con la industria farmacéutica en el desarrollo de nuevas moléculas o ya existentes para distintas indicaciones médicas dermatológicas, mediante la ejecución de estudios de ensayos clínicos de manera ética y bajo la regulación y normatividad nacional.Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo León
Select an option
I am a doctor
I am a sponsor
Specializations
Psoriasis pustulosa generalizada
Diabetes
Covid-19
Coronavirus
Carcinoma hepatocelular
Enfermedad de Alzheimer
Fibrosis pulmonar
Leucemia
Nefritis lúpica
Our team
Medical staff
Jorge de Jesús Ocampo Candiani
Diana Flores Alvarado
Perla Martinez Leyva.
Sonia Chávez Álvarez
Minerva Gómez Flores
C. Lucio Vera Cabrera
Osvaldo Vazquez Martinez
Maira Elizabeth Herz Ruelas
Carmen Molina Torres
Alejandra Villarreal Martínez
Fania Zamantta Muñoz Fuentes
Erika Lizbeth Alba Rojas
Adrián Cuellar Barboza
Gabriela Zapata González
Maria Elena Deveze Villarreal
Myrthala Juarez
Elizabeth Arias Reyes
Erasmo Saucedo Uribe
Javier Garza
Adrián Rendón
Brenda Nohemi Lozano
Berenice Soto
Perla R Colunga Pedraza
Open studies
Breast Cancer
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) - heredERA - Hoffmann-La RocheSee more
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies - PfizerSee more
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - PfizerSee more
Arthritis
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and CompanySee more
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - I4V-MC-JAHU - Eli Lilly and CompanySee more
Head and neck cancer
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies - PfizerSee more
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 - AHEAD-MERIT - BioNTech SESee more
Lung cancer
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases - Hoffmann-La RocheSee more
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - PfizerSee more
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-1 - BiogenSee more
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers SquibbSee more
Cardiovascular disease
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
Esophageal cancer
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more
Gastric cancer
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more
Gastroesophageal cancer
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers - HERIZON-GEA-01 - Zymeworks Inc.See more
Leukemia
Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia - Fernando De la Garza SalazarSee more
Liposarcoma
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - PfizerSee more
Lymphoma
Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma - Hospital Universitario Dr. Jose E. GonzalezSee more
Obesity
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
Ocular Graft versus Host Disease
Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT - Hospital Universitario Dr. Jose E. GonzalezSee more
Periodontitis
Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft - Lynch Biologics LLCSee more
Prostate cancer
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - PfizerSee more
Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer IngelheimSee more
Solid tumors
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors - CDK4i - PfizerSee more
